Pamidronic Acid

Pamidronic Acid

SCHEMBL8850008

NCCC(O)(P(=O)(O)O)P(=O)(O)O.O.O.O.O.O

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

FDPS

The experimentally established mechanism targets of Pamidronic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
FDPS known ✓ P14324 19/20 0.95
PDE3A Q14432 2/20 0.95
LMNA P02545 1/20 0.95
ADRB3 P13945 1/20 0.95
PDE4D Q08499 1/20 0.95
GGPS1 O95749 7/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pamidronic Acid SCHEMBL5718109 0.97 FDPS (0.90) FDPSPDE3ALMNAADRB3PDE4D
Pamidronic Acid SCHEMBL18361 0.97 FDPS (1.00) FDPSPDE3ALMNAADRB3PDE4D
Pamidronic Acid SCHEMBL2787529 0.95 FDPS (0.95) FDPSPDE3ALMNAADRB3PDE4D
Pamidronic Acid SCHEMBL8642786 0.95 FDPS (0.95) FDPSPDE3ALMNAADRB3PDE4D
Pamidronic Acid SCHEMBL570527 0.95 FDPS (0.95) FDPSPDE3ALMNAADRB3PDE4D
Pamidronic Acid SCHEMBL31388517 0.95 FDPS (0.95) FDPSPDE3ALMNAADRB3PDE4D
Pamidronic Acid SCHEMBL7755905 0.88 FDPS (0.82) FDPSPDE3ALMNAADRB3PDE4D
Alendronic Acid SCHEMBL303564 0.85 FDPS (0.95) FDPSPDE3ALMNAADRB3PDE4D
Alendronic Acid SCHEMBL167772 0.85 FDPS (0.95) FDPSPDE3ALMNAADRB3PDE4D
Pamidronic Acid SCHEMBL2641229 0.84 FDPS (0.68) FDPSPDE3ALMNAADRB3PDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022214707-A1 CELLULAR REPORTER AND METHODS OF USING THE SAME GADETA B.V. (NL) 2022-10-13 WO disclosed
EP-0617624-B1 TREATMENT OF PERIODONTAL DISEASE WITH ALENDRONATE MERCK & CO INC (US) 1997-03-26 EP disclosed
EP-0617624-A1 TREATMENT OF PERIODONTAL DISEASE WITH ALENDRONATE. MERCK & CO INC (US) 1994-10-05 EP disclosed
US-5270365-A Prevention and treatment of periodontal disease with alendronate MERCK & CO., INC. (US) 1993-12-14 US disclosed
WO-1993011774-A1 TREATMENT OF PERIODONTAL DISEASE WITH ALENDRONATE MERCK & CO., INC. (US) 1993-06-24 WO disclosed